CAMPBELL DUFFY: Open Payments
NPI 1598452633 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,063 in 33 payments from 20 companies in 2025. Trend: 2023 $74 · 2024 $454 · 2025 $1,063
Food & beverage: $1,063
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 1 | $139 |
| BeOne Medicines USA, Inc. | 1 | $131 |
| Legend Biotech USA Inc. | 1 | $119 |
| SOBI, INC | 4 | $86 |
| ABBVIE INC. | 3 | $73 |
| Incyte Corporation | 3 | $72 |
| Janssen Biotech, Inc. | 3 | $60 |
| Merck Sharp & Dohme LLC | 2 | $49 |
| Daiichi Sankyo Inc. | 2 | $43 |
| Karyopharm Therapeutics Inc. | 2 | $43 |
Products named: Xospata, BRUKINSA, CARVYKTI, Vonjo, EPKINLY, MONJUVI, Vanflyta, XPOVIO.
Industry payments across CO — which companies pay providers there.
